IL-6 trans-signaling is driven by ectodomain shedding of the IL-6R and has been shown to be a critical event in inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease [9]. This evidence concerns the gene IL6R and inflammatory bowel disease.